STCBIOSTCBIO
STCBIO
  • About Us
    • Business Philosophy
      • Business Ideology
      • Business Principles
      • Vision
      • CI
    • Founder
      • Kye-Ho Lee
      • Social Contribution
    • STC Introduction
      • STC LIFE
      • STC NARA
      • bBHC
      • 97.7 B&H
    • History
    • How to Find Us
  • Research & Development
    • STRI
    • New Drug Research & Development Center
    • Agricultural Life Science Research Center
    • Life Science R&D Center
    • Gene Research Center
  • Major Products
    • ENERGY WATER
    • Cell97.7
    • CELGEN
    • LAMU
    • EIS
    • Customized Cosmetics
    • Food Supplements
  • PR
    • STC in News
    • STC PR
Menu back  
 
  • CORPORATE SITE LinkedIn
  • LANGUAGE
    • ENGLISH
    • KOREAN
    • CHINESE
    • CORPORATE SITE LinkedIn
    • About Us
      • Business Philosophy
        • Business Ideology
        • Business Principles
        • Vision
        • CI
      • Founder
        • Kye-Ho Lee
        • Social Contribution
      • STC Introduction
        • STC LIFE
        • STC NARA
        • bBHC
        • 97.7 B&H
      • History
      • How to Find Us
    • Research & Development
      • STRI
      • New Drug Research & Development Center
      • Agricultural Life Science Research Center
      • Life Science R&D Center
      • Gene Research Center
    • Major Products
      • ENERGY WATER
      • Cell97.7
      • CELGEN
      • LAMU
      • EIS
      • Customized Cosmetics
      • Food Supplements
    • PR
      • STC in News
      • STC PR
    December 3, 2014NewsBy stcbio

    STC Successfully Differentiates its Pluripotent Stem Cell into a Pancreas Cell

    STC Successfully Differentiates its Pluripotent Stem Cell into a Pancreas Cell

    – Treating diabetes using pancreas cell

    Maeil Business Daily

    December 3, 2014

    STC Life subsidiary Stem Cell Treatment & Research Institute (STRI, www.stcstri.com)announced that they have successfully differentiated its Newly Elicited Pluripotent Stem Cells without side effects by natural compound (STC -nEPS) into a β cell, with an insulin control function inside a pancreas. Not only is the STC-nEPS without side effects but it is also capable of differentiating into every organs and tissues.

    Upon developing the Newly Elicited Pluripotent Stem Cells without side effects by natural compound (STC -nEPS), STRI (Stem Cell Treatment & Research Institute) researchers have induced its differentiation into a β cell and after seven days have confirmed that the STC-nEPS was transformed into a β cell. Furthermore tracking of the insulin genes characteristic of the β cell showed that a complete β cell was created.

    On top of the successful differentiation of the β cell , research team at STRI(Stem Cell Treatment & Research Institute) also succeeded in differentiating the same into multiple cells within a short period of time. Excellent safety of the research outcome showing no side effects is expected to be immediately applicable in treating diabetes patients.

    “Development of the technology that successfully differentiated a Newly Elicited Pluripotent Stem Cells without side effects by natural compound (STC -nEPS) into the pacreas β cell will not only alleviate symptoms but will be able to treat the fundamentals of what created the illness. With the Newly Elicited Pluripotent Stem Cells without side effects by natural compound (STC -nEPS) and development of the cell differentiation technology, STC Life will be able to lead the world stem cell industry to develop related cell treatments that will make us become a world leading life science company.,” remarked Kye-ho Lee, Chairman of STC Life.

    Established in 1989, STC Life has developed Newly Elicited Pluripotent Stem Cells without side effects by natural compound (STC -nEPS). STC Life specializes in the research and development of stem cells, new drugs and gene related to controlling oxygen free radical inside human body(p62), life sciences, along with agricultural research and development using energy water.

    BACK
    Related posts
    Treatment of acute ischemic stroke by minimally manipulated umbilical cord-derived mesenchymal stem cells transplantation: A case report
    August 24, 2021
    Psoriasis treatment using minimally manipulated umbilical cord-derived mesenchymal stem cells: A case report
    August 24, 2021
    Alopecia treatment using minimally manipulated human umbilical cord-derived mesenchymal stem cells: Three case reports and review of literature
    August 24, 2021
    No title
    July 31, 2020
    STRI PERFECTS STEM-CELL PLURIPOTENCY TO ENABLE 3D PRINTING OF HUMAN ORGANS
    April 17, 2020
    460 patents regarding nEPS are registered in 147 countries.
    March 19, 2020
    PR
    • STC in News
    • STC PR
    • About Us
      • Business Philosophy
        • Business Ideology
        • Business Principles
        • Vision
        • CI
      • Founder
        • Kye-Ho Lee
        • Social Contribution
      • STC Introduction
        • STC LIFE
        • STC NARA
        • bBHC
        • 97.7 B&H
      • History
      • How to Find Us
    • Research & Development
      • STRI
      • New Drug Research & Development Center
      • Agricultural Life Science Research Center
      • Life Science R&D Center
      • Gene Research Center
    • Major Products
      • ENERGY WATER
      • Cell97.7
      • CELGEN
      • LAMU
      • EIS
      • Customized Cosmetics
      • Food Supplements
    • PR
      • STC in News
      • STC PR

    STC Group Co.,Ltd  |  72 UN Village-gil, Yongsan-gu Seoul (04420) South Korea
    TEL. 080-718-0120  |  FAX. 02-511-6419

    Copyright@2017 by STC Group Corporation Co.Ltd . All Rights reserved. Designed by NXweb

      • STRI
      • Energy water
      • All that skin
      Famliy Site